Lynch Syndrome and Skin: A Dermatologist’s Perspective

Dana-Farber Cancer Institute

V. Nambudiri

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Year in Review: Bowen Diseases and Squamous Cell Carcinoma of the Na…

Dermatology 2024 Year in Review

J. Dominguez-Cherit

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

Update in Treatment of Advanced Non-Melanoma Skin Cancers

Cleveland Clinic Dermatology & Plastic Surgery Institute

A. Vij

Neoadjuvant Immunotherapy in Advanced cSCC

Vishal Patel

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

Molecular vs. Multidisciplinary Tumour Boards in Skin Cancers

Alberto Cunquero

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

Oncolytic Viral Therapies in the Treatment of Melanoma and Other Ski…

Melanoma Research Foundation

G. In

Updates on Neoadjuvant IO for Non-Melanoma Skin Cancer

Neil Gross

Year in Review: Updates in Non-Melanoma Skin Cancers

Dana-Farber Cancer Institute

K. Khaddour

Understanding Skin Cancer: Diagnosis, Biopsy, Risks, and Treatment O…

Yale Cancer Center

J. Clune

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

Neoadjuvant IO: Non-Melanoma Skin Cancer

ImmunoTherapy Bridge 2023

N. Gross

How Do You Undertake a Multidisciplinary Approach to SCC Management?

dermsquared

L. Korb Ferris

Non-Melanoma Skin Cancers

ImmunoTherapy Bridge 2023

P. A. Ascierto

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC …

Insights from 2023 ESMO Annual Meeting

N. Gross

Management of High Risk Squamous Cell Carcinoma

NYU Langone

M. L. Stevenson

Updates in non-Melanoma Skin Cancer

Head and Neck Symposium: Skin Malignancies Update

S. Daveluy